Shenzhen Salubris Pharmaceuticals Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shenzhen Salubris Pharmaceuticals Co Ltd with three other
companies in this sector in China:
Tianjin Chase Sun Pharmaceutical Company Limited
sales of 3.35 billion Chinese Renmimbi [US$494.80 million]
of which 50%
was Finished Medicine),
China Medical System Holdings Limited
(3.55 billion Chinese Renmimbi [US$525.13 million]
of which 100%
was Pharmaceutical Products), and
Zhejiang Huahai Pharmaceutical
(3.50 billion Chinese Renmimbi [US$517.25 million]
of which 52%
was Raw material & Intermediate Sale).
During the year ended December of 2015, sales at
Shenzhen Salubris Pharmaceuticals Co Ltd were 3.48 billion Chinese Renmimbi (US$513.93 million).
increase of 20.6%
versus 2014, when the company's sales were 2.88 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Shenzhen Salubris Pharmaceuticals Co Ltd
(and since 2010, sales have increased a total of 168%).
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
513.9% in 2015, from
222,914.43 Chinese Renmimbi to 1.37 million Chinese Renmimbi.